Oppenheimer Asset Management Inc. Makes New Investment in Cardinal Health, Inc. $CAH

Oppenheimer Asset Management Inc. acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 3,921 shares of the company’s stock, valued at approximately $659,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CAH. Atlantic Edge Private Wealth Management LLC grew its position in Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares during the last quarter. Greykasell Wealth Strategies Inc. purchased a new stake in Cardinal Health in the 1st quarter worth approximately $26,000. GW&K Investment Management LLC boosted its holdings in Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after buying an additional 144 shares in the last quarter. Harbor Asset Planning Inc. purchased a new stake in Cardinal Health during the second quarter worth $49,000. Finally, Pittenger & Anderson Inc. lifted its holdings in Cardinal Health by 366.7% during the second quarter. Pittenger & Anderson Inc. now owns 350 shares of the company’s stock valued at $59,000 after purchasing an additional 275 shares in the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Stephen M. Mason sold 41,575 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 over the last ninety days. Insiders own 0.12% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Citigroup lifted their target price on shares of Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research note on Friday. Robert W. Baird set a $232.00 price target on Cardinal Health in a research note on Friday. Evercore ISI lifted their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research report on Friday. Argus set a $189.00 price objective on shares of Cardinal Health in a report on Friday, August 22nd. Finally, Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a research report on Tuesday, August 12th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $176.87.

Cardinal Health Trading Up 0.4%

Shares of CAH stock opened at $190.65 on Friday. The company’s fifty day simple moving average is $155.17 and its 200-day simple moving average is $154.51. Cardinal Health, Inc. has a 52 week low of $107.11 and a 52 week high of $197.67. The company has a market cap of $45.29 billion, a PE ratio of 29.56, a P/E/G ratio of 1.39 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same period last year, the company posted $1.88 earnings per share. The firm’s revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were issued a dividend of $0.5107 per share. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.1%. Cardinal Health’s dividend payout ratio is 31.63%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.